Physician profile
Francis K Hackett
NPI 1215990726
$40,420.80
in general payments reported to CMS, 2019-2025
10 companies · $7,604 in 2025
The $7,604 reported for 2025 was more than what 75% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $4,234 · 2021: $3,688 · 2022: $4,107 · 2023: $3,993 · 2024: $5,573 · 2025: $7,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $3,521 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,613.00 |
| Travel and Lodging | $3,521.07 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Food and Beverage | $1,035.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24,524.60 | 2021-2025 | Arctic Front Advance, Affera Mapping System, Pulseselect |
| Medtronic Vascular, INC. | $15,431.58 | 2019-2020 | |
| Cardiva Medical, INC. | $168.17 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Boston Scientific Corporation | $100.60 | 2024 | |
| Novartis Pharmaceuticals Corporation | $56.22 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $53.76 | 2022-2023 | Farxiga, Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.34 | 2024 | Lifevest |
| Esperion Therapeutics, INC. | $24.75 | 2020 | |
| Abbott Laboratories | $16.82 | 2023 | Ensite |
| Janssen Pharmaceuticals, INC | $12.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Hackett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.